cefaclor anhydrous has been researched along with Cross Infection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrower, AD | 1 |
| Carpentier, M; Delmée, M; Glupczynski, Y; Gordts, B; Magerman, K; Simon, A; Surmont, I; Van de Vyvere, M; Van Landuyt, H; Van Nimmen, L; Van Noyen, R | 1 |
| Mulligan, ME | 1 |
1 trial(s) available for cefaclor anhydrous and Cross Infection
| Article | Year |
|---|---|
A double-blind study of cefaclor and amoxycillin in home and hospital-acquired infections.
Topics: Amoxicillin; Cefaclor; Cephalexin; Cross Infection; Double-Blind Method; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 1982 |
2 other study(ies) available for cefaclor anhydrous and Cross Infection
| Article | Year |
|---|---|
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefotaxime; Cefuroxime; Child; Child, Preschool; Clarithromycin; Clavulanic Acids; Cross Infection; Haemophilus Infections; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Middle Aged | 1996 |
In vitro activity of cefixime and six other agents against nosocomial pathogens of the Enterobacteriaceae family.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalothin; Cross Infection; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |